Pulmonary Fibrosis News Forums Forums BioNews Content Flash Briefings & Podcasts Blade Therapeutics Announced Its Acquisition of Atxco and Lead Anti-Fibrosis Candidate PAT-409

  • Blade Therapeutics Announced Its Acquisition of Atxco and Lead Anti-Fibrosis Candidate PAT-409

    Posted by pulmonary-fibrosis-news-moderator on November 21, 2019 at 8:32 am

    Senior Director of Multichannel Content for Pulmonary Fibrosis News, Michael Morale, discusses how Blade Therapeutics announced its acquisition of Atxco, and its lead anti-fibrosis candidate PAT-409.

    Are you interested in learning more about Pulmonary Fibrosis? If so, please visit pulmonaryfibrosisnews.com/

    What do you think about this news? Listen to this flash briefing episode and share your thoughts in the comment section below!

  • 0 Replies

Sorry, there were no replies found.

Log in to reply.